Latham & Watkins LLP represents the underwriters in the offering while Wilson Sonsini Goodrich & Rosati advised Reneo Pharmaceuticals, Inc. Reneo Pharmaceuticals, Inc. has announced the pricing...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Crossover Health in the transaction. Crossover Health, a relationship-based, tech-enabled, national healthcare organization that integrates both virtual and in-person care for...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP advised Blend in the transaction, while Wachtell, Lipton, Rosen & Katz advised Mr. Cooper Group. Blend, a leader in digital lending software,...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP acted as Hippo’s legal counsel, while Sullivan & Cromwell LLP served as Reinvent’s legal counsel for the transaction. Davis Polk advised the...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Angion in the offering and private placement. Angion Biomedica Corp. (NASDAQ:ANGN) has announced the pricing of its initial public offering of 5...
You must be a Standard 1 Year member to access this content.
